United States· US:0597-0152_09daa78d-f417-436c-a29e-029c015ca6d6

Jardiance

A empagliflozin product containing empagliflozin, registered in United States by Boehringer Ingelheim Pharmaceuticals, Inc.. The same ATC class is registered in 16 of our 19 countries.

ATC A10BK03US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about empagliflozinAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Empagliflozin is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BK03 (empagliflozin), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
9 of them publish a price we can compare per daily dose

Search empagliflozin products by name

Empagliflozin · ATC A10BK03

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of empagliflozin costs, country by country.

Normalised to the WHO defined daily dose (17.5 mg), so markets compare like for like.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Empagliflozin · price per daily dose (17.5 mg)

USD · FX 28 Sept 2026

CH Switzerland$3.80
IT Italy$2.95

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: EMPAGLIFLOZIN
Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc.
Country: United States (US)
ATC code: A10BK03
ATC class: Empagliflozin
Defined daily dose: 17.5 mg, O
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 8

ndc11
0597015207
1 BOTTLE in 1 CARTON (0597-0152-07) / 7 TABLET, FILM COATED in 1 BOTTLE
ndc11
0597015230
30 TABLET, FILM COATED in 1 BOTTLE (0597-0152-30)
ndc11
0597015237
30 BLISTER PACK in 1 CARTON (0597-0152-37) / 1 TABLET, FILM COATED in 1 BLISTER PACK
ndc11
0597015290
90 TABLET, FILM COATED in 1 BOTTLE (0597-0152-90)
ndc11
0597-0152-07
ndc11
0597-0152-30
ndc11
0597-0152-37
ndc11
0597-0152-90

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

466 interactions on record for empagliflozin.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check empagliflozin against other medicines How interaction checks work

Empagliflozin · interactions on record

466 records

1 severe
425 moderate
40 minor

Most severe, free to view

SucralfateA02BX02moderate
PapaverineA03AD01moderate
ThiethylperazinA04AB03moderate
TriflupromazinA04AD06moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Empagliflozin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All empagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Empagliflozin Denk, Empagliflozin Devatis
Belgium · Empagliflozin Ab, Empagliflozine Hcs
Bulgaria · Глузод, Емлигекса
Cyprus · Glusod
Czechia · Empagliflozin Polpharma, Empelic
Germany · Empagliflozin Devatis, Emprables
Denmark · Bifoglan, Elemio
Estonia · Glusod
Spain · Empagliflozina Aurovitas, Empagliflozina Kern Pharma
Finland · Empagliflozin Devatis, Empagliflozin Reddy
United Kingdom (Northern Ireland) · Empagliflozin, Empagliflozin G.L. Pharma
Greece · Elemio, Empagliflozin Pharmapath
Croatia · Glusod
Hungary · Empagliflozin Polpharma
Ireland · Empagliflozin Krka
Iceland · Empagliflozin Reddy, Empagliflozin Wh 10 Mg
Liechtenstein · Jardiance
Lithuania · Embeflyx, Emlygexa
Luxembourg · Empagliflozin Ab
Latvia · Embeflyx, Emlygexa
Malta · Empagliflozin Denk, Eprekavor
Netherlands · Empagliflozine Devatis, Empagliflozine Doc
Norway · Empagliflozin Devatis, Empagliflozin Reddy
Poland · Empelic
Portugal · Empagliflozina Aurobindo, Empagliflozina Aurovitas
Romania · Glusod
Sweden · Empagliflozin Devatis, Empagliflozin Labiana
Slovenia · Empagliflozin Krka, Glusod
Slovakia · Empagliflozin Polpharma, Glusod

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/52bd73ee-5c97-46c7-89d8-0b0208401fc7
GET /v1/drugs/52bd73ee-5c97-46c7-89d8-0b0208401fc7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "10",
  "substance": "EMPAGLIFLOZIN",
  "productndc": "0597-0152",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA204629",
  "marketing_category": "NDA"
}

API reference MCP server Plans

See everything about empagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console